Cargando…
Drug repositioning is an alternative for the treatment of coronavirus COVID-19
Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different...
Autores principales: | Serafin, Marissa B., Bottega, Angelita, Foletto, Vitória S., da Rosa, Taciéli F., Hörner, Andreas, Hörner, Rosmari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. and International Society of Chemotherapy.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194941/ https://www.ncbi.nlm.nih.gov/pubmed/32278811 http://dx.doi.org/10.1016/j.ijantimicag.2020.105969 |
Ejemplares similares
-
Anti-infective properties of proton pump inhibitors: perspectives
por: da Rosa, Taciéli Fagundes, et al.
Publicado: (2021) -
Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use
por: Foletto, Vitória Segabinazzi, et al.
Publicado: (2022) -
Drug repositioning, a new alternative in infectious diseases
por: Serafin, Marissa Bolson, et al.
Publicado: (2018) -
Pneumonia caused by Bordetella bronchiseptica in two HIV-positive patients: Pneumonia causada por Bordetella bronchiseptica em dois pacientes HIV-positivos
por: Rampelotto, Roberta Filipini, et al.
Publicado: (2016) -
Clinical trials on drug repositioning for COVID-19 treatment
por: Rosa, Sandro G. Viveiros, et al.
Publicado: (2020)